Nystatin for Koi Fish: Uses, Dosing & What Owners Should Know

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Nystatin is an antifungal medication in the polyene class. In veterinary medicine, it is best known for treating localized yeast infections, especially those caused by Candida. It is commonly used in dogs, cats, birds, and other species for infections involving the mouth, skin folds, or gastrointestinal tract. It is not a routine first-line medication for common koi pond fungal problems.

That distinction matters. Many visible "fungal" problems in koi are actually water molds such as Saprolegnia, bacterial ulcers with secondary fuzz, or parasite-related skin damage. Those conditions often need a different plan, such as water-quality correction, parasite testing, wound care, topical antiseptics, or other antifungal agents selected by your vet.

For koi, nystatin would usually be considered only in specific, uncommon situations where your vet suspects a localized yeast-type infection and believes this medication fits the organism involved. Because fish medicine is highly species- and environment-dependent, nystatin use in koi is generally extra-label and should be guided by an aquatic veterinarian.

In general veterinary medicine, nystatin is used for mucocutaneous candidiasis and other localized yeast infections. It works by binding to fungal cell membranes. Because it is poorly absorbed from the gastrointestinal tract, it is most useful where your vet wants a local effect rather than whole-body treatment.

In koi, that means nystatin is not usually the medication used for pond-wide fungal outbreaks or classic cottony external lesions. Common koi skin and gill problems are more often linked to water quality stress, parasites, bacterial disease, or water molds, and those problems need diagnosis before treatment. Treating the wrong cause can delay recovery and increase losses in the pond.

Your vet may discuss nystatin only if there is concern for a localized yeast problem, often after examining skin scrapings, cytology, culture, or the fish's response to prior treatment. If your koi has white patches, ulcers, frayed fins, flashing, clamped fins, or lethargy, the most helpful next step is usually diagnostics and water testing, not guessing based on appearance alone.

Do not dose nystatin in koi without your vet's instructions. There is no widely accepted, standard at-home dosing protocol for koi that is as established as dosing in dogs or cats. In fish, the right plan depends on the suspected organism, lesion location, fish size, water temperature, salinity, filtration setup, and whether treatment is topical, oral, or part of a supervised hospital protocol.

Another challenge is that nystatin is mainly useful for localized contact activity. Since it is not well absorbed from the gut, an oral dose may not help a deep or systemic infection. Likewise, adding medications to pond water without confirming the diagnosis can stress koi, disrupt biofiltration, and expose every fish unnecessarily.

If your vet prescribes nystatin, ask for the dose in exact units or mg, the route to use, the frequency, the duration, and whether the medication should be used on one fish only or the whole system. Also ask what monitoring matters most, such as appetite, buoyancy, feces, lesion appearance, and daily water parameters. For many koi cases, the more important treatment step is correcting the underlying cause rather than escalating medication.

Because nystatin has minimal systemic absorption, serious whole-body side effects are generally considered less likely than with many absorbed antifungals. Even so, koi can still react poorly to handling, oral dosing attempts, formulation additives, or treatment that does not match the real disease process.

Potential concerns your vet may want you to watch for include reduced appetite, increased stress during handling, worsening lethargy, abnormal swimming, more mucus production, or lesion progression despite treatment. If an oral formulation is used, gastrointestinal upset is a recognized adverse effect in other species, including loose stool, nausea, or vomiting. In fish, those signs may be harder to recognize directly, so your vet may focus more on appetite, fecal changes, and behavior.

Contact your vet promptly if your koi becomes more listless, stops eating, isolates, develops rapid gill movement, rolls, loses buoyancy control, or the skin lesion spreads. Those changes may mean the original diagnosis was incomplete, the infection is deeper than expected, or the fish is reacting to handling or another part of the treatment plan.

Published fish-specific interaction data for nystatin are limited, so your vet will usually make decisions based on the formulation used, route of administration, and the rest of the treatment plan. That is one reason it is important to tell your vet about every product in the pond or quarantine tank, including salt, formalin-based products, malachite green, methylene blue, antibiotics, dechlorinators, sedatives, and water conditioners.

Nystatin itself is not known for the same level of systemic drug interactions seen with some absorbed antifungals, because it is poorly absorbed. Still, combining multiple medications can make it harder to tell which treatment is helping, which one is irritating tissue, and whether water quality or biofilter function is changing.

The biggest real-world interaction risk in koi medicine is often not a classic drug-drug interaction. It is stacking treatments without a diagnosis. If your koi is already receiving ulcer care, parasite treatment, sedation for exams, or pond-wide medications, ask your vet whether nystatin adds value, whether it should be delayed, and how to monitor the fish and filtration system safely.